Danylo Voievodkin received’t be making his UFC debut anytime quickly.
On Thursday, the UFC revealed Voievodkin accepted a 24-month suspension from Fight Sports activities Anti-Doping (CSAD) for a violation of the UFC’s anti-doping coverage. With no mitigating elements, Voievodkin is no longer eligible to compete till Nov. 10, 2026.
Per the discharge, Voievodkin examined constructive for meldonium, a prohibited substance below the category of Hormone and Metabolic Modulators on the UFC’s banned substances checklist. Voievodkin examined constructive from an out-of-competition pattern collected on Oct. 17 in Vilnius, Lithuania.
Per the USADA web site, meldonium is an anti-ischemic drug that “might enhance endurance, enhance rehabilitation following train, and improve activations of the central nervous system.” Meldonium was added to the WADA banned checklist in 2016 and was famously answerable for tennis star Maria Sharapova’s drug take a look at failure on the Australian Open in 2016.
The 24-year-old undefeated Ukranian fighter competed on week seven of the newest season of Contender Collection, submitting Bailey Schoenfelder with a first-round rear-naked choke and incomes a UFC contract. Per the discharge, CSAD decided that Voievodkin’s offending meldonium utilization came about after his Contender Collection bout.
MMA Combating confirmed that following the suspension, Voievodkin was launched from the UFC.
